Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician May 15, 2003 Matthew Neff	Newsletter FDA, CDC Respond to Increasing Threat of SARS... HHS Releases HIPAA-Related Documents on Patient Privacy Standards... New Research Journal, Annals of Family Medicine, to Debut This Month... HHS Announces $15 Million Health Initiative Focused on Prevention
American Family Physician July 15, 2005 Carrie Morantz	Newsletter AMA, AAFP Act to Protect Patients' Access to Prescriptions... AHRQ Releases Updated Guide to Clinical Preventive Services... HHS Awards $80.5 Million in Grants to Reduce Infant Mortality Rates... etc.
American Family Physician November 15, 2003	Newsletter AAFP Congress of Delegates Changes Name of Specialty to Family Medicine... HHS Report Shows Increases in Life Expectancy, Incidence of Diabetes... CDC, AAFP to Work Together on Immunization Project... etc.
Pharmaceutical Executive April 1, 2011	Off-Label But On Point? Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help.
American Family Physician February 15, 2006 Liz Smith	Newsletter FDA Announces New Prescription Drug Information Format... ASTM International Develops Continuity of Care Record... HHS Launches Project to Test Electronic Prescribing for Medicare Part D... etc.
Pharmaceutical Executive June 1, 2011 Jill Wechsler	Educating Physicians A communications program is the main component of a Risk Evaluation and Mitigation Strategy to promote safe use of extended-release or long-acting opioids, which have been the subject of FDA/industry negotiations for several years.
American Family Physician July 15, 2002	Newsletter Awards Are Available to Increase Numbers of Nurses and Quality of Nursing Services... AHRQ Partnership Will Help Turn Research into Improved Care... CDC Report Reveals Significant Decline in Prevalence of Teenaged Smoking... etc.
American Family Physician March 15, 2006 Liz Smith	Newsletter CDC Recommends Increased Influenza Vaccination in Health Care Staff... Health Initiative to Improve Cancer Therapy with Biomarker Evaluation... Pharmaceutical Association Supports Lower Priced Drugs Act... etc.
Pharmaceutical Executive January 1, 2014 Jill Wechsler	Pharma Challenges for 2014 Pricing and personalized medicine are key themes shaping drug development and marketing
Managed Care February 2008 Martin Sipkoff	FDA Approach to Generics May Be a Mixed Blessing A recently announced initiative is supposed to speed approval of generic drugs, but does it address some fundamental flaws in the approval process?
Searcher June 2012 Stephanie C. Ardito	The Medical Digital: How Safe Are the Prescription Drugs we Take? Monitoring Adverse Events and Recalls For general information about prescription and clinical trial drugs, the following websites have been around for a while and have excellent reputations.
American Family Physician September 15, 2002	Newsletter CDC Web Site Provides Current Information on West Nile Virus... AHRQ Survey Details Use of Health Care for Chronic Conditions... HHS Approves Nevada Plan to Insure Women with Breast or Cervical Cancer... HRSA Grants Almost $49 Million to Improve Health Care Facilities... etc.
Pharmaceutical Executive August 1, 2012 Jill Wechsler	Fleshing Out FDASIA Medical apps, e-submissions, counterfeit drugs, and imports tucked into fairly "clean" user-fee renewal legislation. In late June leading legislators reached across party lines to quickly approve the Food and Drug Administration Safety and Innovation Act.
Chemistry World February 14, 2012 Rebecca Trager	FDA proposes biosimilars approval pathway The US Food and Drug Administration has released its long awaited guidance to assist in the development and approval of so-called 'biosimilars' - biological drugs that are very similar to licensed ones.
Managed Care March 2008 Martin Sipkoff	The Epilepsy Battle in the War Between Brands and Generics Brand-name manufacturers and many neurologists see danger in generic substitution, but the FDA insists that the practice is safe
Pharmaceutical Executive May 1, 2011 Jill Wechsler	Outrage Over Drug Prices Stiff price tags draw scrutiny from Congress and consumers, and raise questions about FDA policies
Pharmaceutical Executive June 1, 2014 Jill Wechsler	Compassionate Use Requests Complicate Drug Development Pharma, HCPs, and regulators walk tightrope in addressing early-access push while supporting biomedical R&D.
American Family Physician September 15, 2004 Genevieve Ressel	Newsletter AFMO Launches Web Site for Family Medicine Research... CMS Eliminates Grace Period for Expired Codes... AAFP Publishes Resource for Starting a Medical Practice... AAFP Board Approves Recommendation to Double EB CME Credit... etc.
The Motley Fool October 8, 2007 Brian Orelli	New FDA Regulations for Drugmakers To deal with a growing backlog of pending applications, the FDA plans to stop its first-come, first-served system.
Pharmaceutical Executive December 1, 2013	FDA Pursues Delicate Balancing Act The Agency struggles to ensure access to needed medicines while minimizing potential risks, writes Jill Wechsler.
Pharmaceutical Executive April 1, 2011	Winning Beyond the Molecule It can take both a clinical and non-clinical approach to win the differentiation competition.
American Family Physician July 15, 2006 Liz Smith	Newsletter AMA Announces New Policies on DTC Advertising, Price Transparency... AAP Supports Recommendations of IOM Emergency Care Report... CDC Urges Awareness of Measles in Travelers to World Cup... etc.
Chemistry World March 25, 2010 Rebecca Trager	Big pharma scores in US healthcare reform President Obama has signed the biggest US healthcare reform since the 1960s, and although it is largely seen as a victory for the pharmaceutical industry, some analysts are characterising it as a 'double-edged sword'.
Managed Care March 2008 John Carroll	Should Plans Pay Physicians To Switch Patients to Generics? The AMA calls it a kickback, but the industry sees it as just good practice to give doctors an incentive to get patients on equivalent generics
American Family Physician November 15, 2005 Sarah J. Evans	Newsletter AAFP Survey Shows Increased Use of EHR Systems by FPs... AHRQ Launches New Health Care Program... AAFP Asks Members to Join Title VII Campaign... AHRQ Rewards Over $22.3 Million for Health Information Technology... etc.
Nursing Management November 2011 Mary Ann Remshardt	The Impact of Patient Literacy on Healthcare Practices With regard to patient teaching, how can healthcare personnel be certain that patients understand concepts basic to informed consent, hospital safety, dietary restrictions, and prescription information?
American Family Physician October 15, 2004 Genevieve Ressel	Newsletter Vaccine Manufacturer Expecting Delays in Distribution of Fluvirin... U.S. Census Bureau Report Confirms Rising Number of Uninsured Americans... CDC Reminds Physicians to Consider West Nile Virus in Pregnant Women... etc.
Pharmaceutical Executive April 10, 2014	Obama Policies Reshape Pharma Marketing Health reform initiatives promote transparency, challenge reimbursement, writes Jill Wechsler.
American Family Physician September 15, 2003 Matthew Neff	Newsletter AAFP Launches Initiative to Strengthen Patients' Voices in Congress... New Guide Available Online to Help Physicians Counsel Older Drivers... Fact Sheet Outlines Health Issues for Patients to Address with Physicians... etc.
American Family Physician November 15, 2000 Rosemarie Sweeney & Toni Lapp	Newsletter Coalition Report Focuses on Care at the End of Life... AHRQ Urges Research on Bioterrorism Threat... AAFP Members Deliver Care Packages to Azerbaijan... HHS Creates Organ Transplant Advisory Panel... Healthy People Encouraged to Wait for Influenza Vaccine...
Pharmaceutical Executive January 1, 2012 Jill Wechsler	New Year, New Issues Look for action in 2012 on drug access, shortages, innovation, and transparency. The 800-pound gorilla in the room is the looming Supreme Court decision on the constitutionality of the Obama health reform legislation.
American Family Physician October 1, 2000	AAFP Core Educational Guidelines Recommended Core Educational Guidelines For Family Practice Residents...
American Family Physician March 15, 2004	Newsletter A recent report by the Institute of Medicine (IOM) urges educators and other groups to focus more attention on strategies for reducing barriers that deny minorities access to careers in the health professions.
American Family Physician March 15, 2007	Newsletter Title VII Funds Increase in 2007 Continuing Appropriations Resolution... Medicaid Enrollment Numbers Fall After Introduction of New Rule... AAFP Responds to HPV Vaccination Requirement for School Entry... etc.
American Family Physician December 15, 2005 Sarah J. Evans	Newsletter AAFP, ACP, AOA Urge Congress to Stop Medicare Payment Cuts... HHS Awards Emergency Health Care Aid to Louisiana Katrina Victims... HHS Grants Contracts for Nationwide Health Information Network... etc.
The Motley Fool March 31, 2011 Brian Orelli	Drug Warning Labels: The Good, Bad, and Ugly Once a drug is approved, investors can't fall asleep and ignore FDA announcements about drugs. They come in different varieties, but warnings tend to be of the bad and ugly variety more often than the good.
Pharmaceutical Executive March 1, 2013 Jill Wechsler	Another Round of FDA Legislation? Pressure for action on key enforcement and regulatory issues may prompt congressional action this year.
Pharmaceutical Executive March 1, 2011 Jerry Coamey	Engage the Physician! New research shows that gauging the mind of the clinician is crucial to timely uptake of the new diagnostic tools offered by the genomic revolution
The Motley Fool December 31, 2010 Brian Orelli	2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions.
Managed Care May 2006 John Carroll	Effective Ways To Increase Usage of Generics Generics is one of the few areas where insurance plans can economize effectively. BlueCross & BlueShield of North Carolina is one of many insurers that are changing members' and prescribers' behavior.
Pharmaceutical Executive August 1, 2012	Sunny Outlook for Biopharm 2020? Albert Wertheimer looks beyond today's dark clouds with a comparatively sunny forecast for the biopharm industry in 2020. Just watch out for the harsh light of complacency.
American Family Physician August 1, 2005 Safeer & Keenan	Health Literacy: The Gap Between Physicians and Patients Inadequate health literacy can result in difficulty accessing health care, following instructions from a physician, and taking medication properly. Patients with inadequate health literacy are more likely to be hospitalized than patients with adequate skills.
Bio-IT World August 13, 2003 Brian Reid	Remaking the FDA New commissioner is pushing for greater use of technology and innovation to speed the flow of drugs to market.
American Family Physician September 15, 2005 Carrie Morantz	Newsletter AAFP Web Resource Answers Questions About Medicare Part D ... Ambulatory Care Quality Standards Endorsed by NQF... NIGMS Allocates $9 Million to Centers for Stem Cell Research... etc.
The Motley Fool October 16, 2006 Brian Lawler	The Coming Generic Drug Boom Generic drugmakers are poised to profit from several key factors. Investors, take note.
The Motley Fool November 12, 2009 Brian Orelli	The Life-and-Death Situation That Isn't Branded-drug makers aren't playing fair because they refuse to sell samples to generic drug makers.
Pharmaceutical Executive March 1, 2012 Ron Cohen	FDA's Necessary Dose of Reality There's no fast-acting salve, but there are several steps that can be taken to streamline many of the procedures at FDA. And it begins with leadership.
Pharmaceutical Executive July 1, 2014 Jill Wechsler	Pre-emption and States' Rights Pharma backs federal standards for compassionate use, drug importing, data transparency, and track-and-trace.
Pharmaceutical Executive September 1, 2012 Al Topin	Doctors' Words No Longer Gospel In the digital age, physicians don't call the shots when it comes to healthcare guidance. Marketers must appeal to multiple sources in seeking ways to garner patient adherence and loyalty.
The Motley Fool February 11, 2010 Brian Orelli	A Turnaround Year, But Not in a Good Way 2009 was a solid year for sanofi-aventis thanks to a boost from sales of swine flu vaccine and some help from the exchange rate. But 2010? Not so solid.